SVA [SINOVAC BIOTECH] 6-K: Sinovac Announces Positive Preliminary Results of Phase I/II
[Sinovac Announces Positive Preliminary Results of Phase I/II Clinical Trials for Inactivated Vaccine Candidate Against COVID-19 Beijing-June 13, 2020 — Sinovac Biotech Ltd. (“Sinovac” or the “ Company”)(Nasdaq: SVA), a leading provider of biopharmaceutical products in China, today announced positive]